The impact of screen exposure on symptom severity and desmopressin treatment outcomes in primary monosymptomatic nocturnal enuresis
Abstract
Purpose: This study aimed to investigate the relationship between daily screen exposure duration, symptom severity, and desmopressin treatment success in children with primary monosymptomatic nocturnal enuresis.
Materials and methods: A retrospective cohort study was conducted on children aged five years and older diagnosed with primary monosymptomatic nocturnal enuresis between January 2020 and January 2026. Patients were categorized into three groups based on daily screen exposure: 0-1 hour (n=141), 1-2 hours (n=139), and more than 2 hours (n=190). Symptom severity was classified as mild, moderate, or severe based on weekly wet nights. Treatment response to oral desmopressin lyophilisate was evaluated after three months and categorized as complete, partial, or no response.
Results: Higher screen exposure was significantly associated with increased symptom severity (p<0.001). In the group with more than 2 hours of exposure, 74.7% of patients had severe symptoms, compared to 39.0% in the 0-1 hour group. Regarding treatment outcomes, desmopressin efficacy decreased as screen time increased (p<0.001). The complete response rate was 36.8% in the 0-1 hour group and 34.8% in the 1-2 hour group but dropped to 20.6% in the group with more than 2 hours of screen exposure. Furthermore, the no-response rate was highest in the group for more than 2 hours at 46.3%.
Conclusion: In this study, higher levels of daily screen exposure were associated with greater symptom severity and lower desmopressin response rates in children with primary monosymptomatic nocturnal enuresis. Assessment of screen habits may be considered a component of behavioral urotherapy counseling.
Keywords
Ethical Statement
References
- Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2016;35(4):471-481. doi:10.1002/nau.22751
- Nevéus T, Fonseca E, Franco I, et al. Management and treatment of nocturnal enuresis-an updated standardization document from the International Children's Continence Society. J Pediatr Urol. 2020;16(1):10-19. doi:10.1016/j.jpurol.2019.12.020
- Bower WF, Moore KH, Shepherd RB, Adams RD. The epidemiology of childhood enuresis in Australia. Br J Urol. 1996;78(4):602-606. doi:10.1046/j.1464-410x.1996.13618.x
- Collis D, Kennedy Behr A, Kearney L. The impact of bowel and bladder problems on children's quality of life and their parents: a scoping review. Child Care Health Dev. 2019;45(1):1-14. doi:10.1111/cch.12610
- Pedersen MJ, Rittig S, Jennum PJ, Kamperis K. The role of sleep in the pathophysiology of nocturnal enuresis. Sleep Med Rev. 2020;49:101228. doi:10.1016/j.smrv.2019.101228
- Glazener CM, Evans JH. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev. 2002;(3):CD002112. doi:10.1002/14651858.CD002112
- Demirbas A, Gercek HG. The effect of screen time on the presentation and treatment of primary monosymptomatic nocturnal enuresis. BMC Urol. 2023;23(1):22. doi:10.1186/s12894-023-01175-5
- Cetinkaya E, Aksoy G, Comak E, Koyun M, Akman S. Screen exposure in paediatric patients with nocturnal enuresis. Nefroloji Hemsireligi Derg. 2025;20(2):109-114. doi:https://doi.org/10.47565/ndthdt.2025.103
Details
Primary Language
English
Subjects
Urology
Journal Section
Research Article
Publication Date
July 10, 2026
Submission Date
March 21, 2026
Acceptance Date
June 1, 2026
Published in Issue
Year 2026 Volume: 19 Number: 3
